EGFR overexpression was observed in most clinically aggressive subtypes of breast cancer, including triple-negative breast cancer and inflammatory breast cancer [18, 38], and predicted poor prognosis in cancer patients [19]. Here, EGFR is linked to inflammatory breast carcinoma.